# Voyager Therapeutics, Inc.: Form 8-K, filed Jun 10, 2026

- Company: [Voyager Therapeutics, Inc.](/companies/vygr.md) (CIK 1640266)
- Form: 8-K
- Filed: 2026-06-10
- Accepted by EDGAR: Jun 10, 2026, 16:05 ET
- Period: 2026-06-09
- Accession: 0001104659-26-072324
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1640266/000110465926072324/tm2617230d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1640266/000110465926072324/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1640266/000110465926072324/tm2617230d1_8k.htm

Filed Jun 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-072324. Last ingested by Listed: Nov 5, 2026, 16:29 ET. No prices; not investment advice.